Novel selective 5-hydroxytryptamine type 2C (5-HT2C) receptor agonist

Novel anti-HIV CCR5 antagonist

Potent FAAH Inhibitor

Long-lasting ergosterol biosynthesis inhibitor

Novel AMPA receptor potentiator with little agonistic effect, producing antidepressant-like effect without causing psychotomimetic effects

Novel inhibitor of the Klebsiella pneumoniae VapBC toxin-antitoxin (TA) system, acting as antimicrobial agents by disrupting the VapBC complex and activating VapC

Novel potent p53-MDM2/X antagonist, inhibiting MDM2 potently with a Ki value of 58 nmol/L, inducing accumulation of p53, p21 and MDM2, inhibiting cell cycle progression of U-2 OS cells at G1 phase in a p53-dependent manner

Novel Potent Dual AChE/GSK-3 Inhibitor for the Treatment of Alzheimers Disease

Novel Irriversible Inhibitor of Parasite Motility and Invasion

Novel Inhibitor of Parasite Motility and Invasion

Novel Inhibitor of Parasite Motility and Invasion

Natural radical scavenger on ABTS

Novel inhibitor of the catalytic functions of peroxiredoxin (Prx) and thioredoxin (Trx) systems

Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein

Novel Inhibitor of Adenovirus Gene Transfer

Novel Inhibitor of Adenovirus Gene Transfer

Novel inhibitor of the type III secretion system (T3SS), acting as a anti-microbial agent against Xanthomonas oryzae pv. oryzae (Xoo)

Type-A trichothecene mycotoxin

Selective class D inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

Selective class B inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

Novel potent PPARγ antagonist with much improved drug-like properties and promising pharmacokinetic profile

Potent and selective CCKA receptor antagonist

Novel COX-2 inhibitor

Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD

K+ channel blocker

Novel microtubule-stablizer

Novel Mycobacterium tuberculosis growth inhibitor

Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence

Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml

Novel inhibitor of the Syk kinase (spleen tyrosine kinase)